Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Exelixis files IND for XL-147

March 19, 2007

Nippon Shinyaku and Teva terminate HMN-214 license agreement

March 19, 2007

Vasostatin-Apo2L enters preclinical research

March 19, 2007

ZK-EPO reported highly effective in a breast cancer bone metastasis model

March 19, 2007

Anticancer compounds disclosed in recent patent literature

March 19, 2007

TG-1042 for cutaneous B-cell lymphoma in phase II trial

March 16, 2007

Tragara closes Series A financing to support oncology and inflammatory programs

March 16, 2007

Nektar advances PEG-irinotecan into phase I

March 16, 2007

Curis selects CUDC-101 from targeted cancer drug development platform

March 16, 2007

Adherex outlines achievements of 2006, updates goals for 2007

March 16, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...